Human hepatitis B virus (HBV) infection remains a serious public health problem worldwide, as it is one of the main risk factors for hepatocellular carcinoma (HCC). Cross-species transmission of HBV has been reported in non-human primates, and pigs may also be infected with HBV or an HBV-like agent. The purpose of this study was to demonstrate the presence of HBV antigens and anti-HBV antibodies in pig sera, providing further support for the existence of HBV or an HBV-like agent in pig populations. The HBV surface antigen (HBsAg) and HBV e antigen (HBeAg) in pig serum samples were detected using HBsAg and HBeAg ELISA Kits, respectively. Antibodies to HBsAg and the Hepatitis B core antigen (HBcAg) in serum samples were also detected using anti-HBsAg and anti-HBcAg antibody ELISA Kits, respectively. HBsAg and HBeAg were detected in 7 of 442 (1.6%) and 7 of 184 (3.8%) pig serum samples, respectively. Furthermore, antibodies specific to HBsAg and HBcAg were identified in 45 of 442 (10.2%) and 39 of 434 (9.0%) pig serum samples, respectively. However, neither HBV DNA nor antibodies to HBeAg were detected in 409 and 298 pig serum samples, respectively. HBV antigens and anti-HBV antibodies were both present in a considerable number of pig serum samples, suggesting that pigs could be infected with a variant HBV or an HBV-like agent. Further studies will be necessary to confirm cross-species infection of pigs with HBV.

Nelumbo nucifera (lotus) is known to be a useful medicinal plant and leaf extract contains several flavonoids and alkaloids. To analyze the effect of Nelumbo nucifera leaves extract (NNL) on the HBsAg production, we treated NNL on HepG2.2.15 cells which contain the hepatitis B viral genome and secrete surface antigen into media. NNL suppressed the production of hepatitis B surface antigen as a dose-dependent manner. To analyze the effect of NNL on HBV DNA replication, PCR analysis was performed. NNL was not affected the HBV DNA replication and HBsAg mRNA expression. To understand the effect of NNL on the production of HBsAg, we carried out the analysis of lipid-metabolizing gene expression using one-step RT-PCR. NNL reduced the gene expression of FASN and SREBP2 and increased the expression of LDLR. Triglyceride content of HepG2.2.15 cells was not decreased by treatment of NNL. This result suggests a possibility that NNL may have an effect for the inhibition of hepatitis B surface antigen by modulation of lipid and cholesterol metabolism.